$BMRN
BioMarin Pharmaceuticals Inc
XNAS•Health Care•Pharmaceutical Preparations
Why is BMRN down today? It is at $67.68 (-2.38%), and our scanner flagged it 54 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BMRN spikes, and full due diligence on BMRN — key stats, earnings, dilution and insider activity. Free.
Get free $BMRN alerts the moment volume spikes
Our scanner flagged $BMRN 54 times in the last 30 days. Create a free account to track $BMRN, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $67.68
- Change today
- -2.38%
- Previous close
- $69.33
- 52-week range
- $49.26 – $70.98
- Market cap
- $13.10B
- Institutional own.
- 99.9%
- Total held
- 99.9%
- Tradeable float
- 194K 0% of shares · after 100% institutions
- Short interest
- 12.5M ▼ -13% vs prior · as of 2026-07-31
- Days to cover
- 7.4d
- Avg daily volume
- 2.3M
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Exchange
- XNAS
- 5mthin
- 218x
- 15mthin
- 218x
- 1hthin
- 0.6x
- 1D
- 0.4x
Get free BMRN + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $BMRN down today?
Here is the latest on BMRN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BMRN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystBioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia,Reported BioMarin to pay $275 million upfront, plus additionalReported Under the terms of the agreement, BioMarin will acquire Alesta and Alesta shareholders will receive an upfront payment of $275 million plus up to $215 million in subsequent payments, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying9 buys, 0 sells last 3 months (19/17 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Anderson Elizabeth M Director | Acquired (grant/award) | +7K | added 22% | 42K | n/a | Jun 2, 26 |
Bodem Barbara W. Director | Acquired (grant/award) | +7K | added 55% | 21K | n/a | Jun 2, 26 |
Clark Ian T Director | Acquired (grant/award) | +7K | added 100% | 14K | n/a | Jun 2, 26 |
Dere Willard H Director | Acquired (grant/award) | +7K | added 19% | 46K | n/a | Jun 2, 26 |
Enyedy Mark J Director | Acquired (grant/award) | +7K | added 55% | 21K | n/a | Jun 2, 26 |
Hombach Robert J. Director | Acquired (grant/award) | +7K | added 18% | 49K | n/a | Jun 2, 26 |
Ho Maykin Director | Acquired (grant/award) | +7K | added 27% | 36K | n/a | Jun 2, 26 |
Walbert Timothy P Director | Acquired (grant/award) | +7K | added 77% | 17K | n/a | Jun 2, 26 |
Countouriotis Athena Director | Acquired (grant/award) | +7K | added 55% | 21K | n/a | Jun 2, 26 |
Hubbard Cristin Officer | Sold (automatic/other) | -2K | sold 5.2% | 42K | $116K at $50.20 | May 20, 26 |
Friberg Gregory R Officer | Sold (automatic/other) | -3K | sold 6.0% | 52K | $177K at $53.85 | May 7, 26 |
Davis George Eric Officer | Sold (automatic/other) | -1K | sold 1.6% | 79K | $71K at $56.05 | Mar 18, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
$BMRN Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$BMRN Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to BMRN
Comparable names in pharmaceutical preparations, closest in size first.
BMRN stock FAQ
Why is $BMRN down today?
Here is the latest on BMRN from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BMRN today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the BMRN stock price today?
BMRN last traded at $67.68, down 2.38% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live BMRN alerts?
The BMRN Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BMRN 54 times in the last 30 days.
What exchange is BMRN on?
BMRN (BioMarin Pharmaceuticals Inc) trades on XNAS, with a market cap of about $13.10B in the PHARMACEUTICAL PREPARATIONS sector.
Is BMRN good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BMRN for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.